A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease

<div>Analysis of predicted MAFLD genes. (a) Venn graph showing the numbers of overlapping genes from DrugBank (red), NCBI Gene (brown), GeneCard (blue), OMIM (yellow), and EZP-related targets (green). (b) The number of predicted genes from each database.</div>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease 

Figure 2 | A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease 